Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer
Clinical trial NCT07683403 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07683403
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-06-30
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.